Distinct functions of AKT isoforms in breast cancer: a comprehensive review

N Hinz, M Jücker - Cell Communication and Signaling, 2019 - Springer
Background AKT, also known as protein kinase B, is a key element of the PI3K/AKT
signaling pathway. Moreover, AKT regulates the hallmarks of cancer, eg tumor growth …

Rationale for targeting fibroblast growth factor receptor signaling in breast cancer

F André, J Cortés - Breast cancer research and treatment, 2015 - Springer
Fibroblast growth factor receptor (FGFR) signaling is involved in multiple biological
processes, including cell proliferation, survival, differentiation, migration, and apoptosis …

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

H Sun, S Cao, RJ Mashl, CK Mo, S Zaccaria… - Nature …, 2021 - nature.com
Abstract Development of candidate cancer treatments is a resource-intensive process, with
the research community continuing to investigate options beyond static genomic …

A natural antisense lncRNA controls breast cancer progression by promoting tumor suppressor gene mRNA stability

M Jadaliha, O Gholamalamdari, W Tang, Y Zhang… - PLoS …, 2018 - journals.plos.org
The human genome encodes thousands of long noncoding RNA (lncRNA) genes; the
function of majority of them is poorly understood. Aberrant expression of a significant …

Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas

A Gonzalez-Aguilar, A Idbaih, B Boisselier… - Clinical cancer …, 2012 - AACR
Purpose: Our objective was to identify the genetic changes involved in primary central
nervous system lymphoma (PCNSL) oncogenesis and evaluate their clinical relevance …

The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains

AA Alekseyenko, EM Walsh, X Wang… - Genes & …, 2015 - genesdev.cshlp.org
NUT midline carcinoma (NMC), a subtype of squamous cell cancer, is one of the most
aggressive human solid malignancies known. NMC is driven by the creation of a …

Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women

D Colak, A Nofal, AB AlBakheet, M Nirmal, H Jeprel… - PloS one, 2013 - journals.plos.org
Breast cancer in young women is more aggressive with a poorer prognosis and overall
survival compared to older women diagnosed with the disease. Despite recent research, the …

Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation

JR Adams, K Xu, JC Liu, NMR Agamez, AJ Loch… - Cancer research, 2011 - AACR
PIK3CA, which codes for the p110α catalytic subunit of phosphatidylinositol 3-kinase, is one
of the most frequently mutated genes in human breast cancer. Here, we describe a mouse …

Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines

M Kadota, HH Yang, B Gomez, M Sato, RJ Clifford… - PloS one, 2010 - journals.plos.org
To gain insight into the role of genomic alterations in breast cancer progression, we
conducted a comprehensive genetic characterization of a series of four cell lines derived …

Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis

M Ramakrishna, LH Williams, SE Boyle, JL Bearfoot… - PloS one, 2010 - journals.plos.org
Ovarian cancer is a disease characterised by complex genomic rearrangements but the
majority of the genes that are the target of these alterations remain unidentified. Cataloguing …